pyrazolo(3,4-d)pyrimidine has been researched along with Leucocythaemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colombo, A; Crespan, E; El-Moghazy, SM; Elbatrawy, AA; George, RF; Kissova, M; Maga, G; Osman, EEA | 1 |
| Bernardo, V; Botta, M; Brullo, C; Carraro, F; Crespan, E; Daigl, H; Dreassi, E; Filippi, I; Maga, G; Musumeci, F; Naldini, A; Radi, M; Schenone, S; Tintori, C; Valoti, M; Zamperini, C | 1 |
2 other study(ies) available for pyrazolo(3,4-d)pyrimidine and Leucocythaemia
| Article | Year |
|---|---|
Novel pyrazolo[3,4-d]pyrimidines as dual Src-Abl inhibitors active against mutant form of Abl and the leukemia K-562 cell line.
Topics: Antineoplastic Agents; Humans; K562 Cells; Leukemia; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrazoles; Pyrimidines; src-Family Kinases; Structure-Activity Relationship | 2016 |
Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study.
Topics: Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Leukemia; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Molecular; Pyrazoles; Pyrimidines | 2011 |